ASCL2 is the master regulator of intestinal stem cell fate, and CXCL8 is an inflammatory chemokine elevated in the CRC tumor microenvironment, playing a crucial role in promoting angiogenesis, invasion, and metastasis [27,28]. The gene discussed is CXCL8; the disease is neoplasm.